nodes	percent_of_prediction	percent_of_DWPC	metapath
Triamcinolone—BCHE—multiple sclerosis	0.0765	1	CbGaD
Triamcinolone—brain cancer—Methylprednisolone—multiple sclerosis	0.0604	0.389	CpDpCtD
Triamcinolone—Corticosteroid Hormone Receptor Agonists—Methylprednisolone—multiple sclerosis	0.0591	0.214	CiPCiCtD
Triamcinolone—Corticosteroid Hormone Receptor Agonists—Betamethasone—multiple sclerosis	0.0569	0.206	CiPCiCtD
Triamcinolone—Corticosteroid Hormone Receptor Agonists—Dexamethasone—multiple sclerosis	0.0569	0.206	CiPCiCtD
Triamcinolone—Corticosteroid Hormone Receptor Agonists—Prednisolone—multiple sclerosis	0.0532	0.193	CiPCiCtD
Triamcinolone—Corticosteroid Hormone Receptor Agonists—Prednisone—multiple sclerosis	0.0503	0.182	CiPCiCtD
Triamcinolone—brain cancer—Dexamethasone—multiple sclerosis	0.0474	0.305	CpDpCtD
Triamcinolone—brain cancer—Betamethasone—multiple sclerosis	0.0474	0.305	CpDpCtD
Triamcinolone—Methylprednisolone—multiple sclerosis	0.0423	0.21	CrCtD
Triamcinolone—Betamethasone—multiple sclerosis	0.0416	0.206	CrCtD
Triamcinolone—Dexamethasone—multiple sclerosis	0.0416	0.206	CrCtD
Triamcinolone—Prednisone—multiple sclerosis	0.0386	0.191	CrCtD
Triamcinolone—Prednisolone—multiple sclerosis	0.0377	0.187	CrCtD
Triamcinolone—SERPINA6—Prednisolone—multiple sclerosis	0.0212	0.223	CbGbCtD
Triamcinolone—NR3C1—Methylprednisolone—multiple sclerosis	0.0155	0.163	CbGbCtD
Triamcinolone—NR3C1—Betamethasone—multiple sclerosis	0.0101	0.106	CbGbCtD
Triamcinolone—NR3C1—Prednisolone—multiple sclerosis	0.00992	0.104	CbGbCtD
Triamcinolone—NR3C1—Prednisone—multiple sclerosis	0.00937	0.0985	CbGbCtD
Triamcinolone—PTGS2—Betamethasone—multiple sclerosis	0.0071	0.0746	CbGbCtD
Triamcinolone—NR3C1—Dexamethasone—multiple sclerosis	0.00585	0.0615	CbGbCtD
Triamcinolone—PTGS2—Dexamethasone—multiple sclerosis	0.00413	0.0434	CbGbCtD
Triamcinolone—CYP3A4—Fingolimod—multiple sclerosis	0.00335	0.0352	CbGbCtD
Triamcinolone—CYP3A4—Methylprednisolone—multiple sclerosis	0.00216	0.0227	CbGbCtD
Triamcinolone—CYP3A4—Mitoxantrone—multiple sclerosis	0.00157	0.0165	CbGbCtD
Triamcinolone—Fluticasone furoate—Dexamethasone—multiple sclerosis	0.00141	0.00955	CrCrCtD
Triamcinolone—Fluticasone furoate—Betamethasone—multiple sclerosis	0.00141	0.00955	CrCrCtD
Triamcinolone—CYP3A4—Betamethasone—multiple sclerosis	0.0014	0.0147	CbGbCtD
Triamcinolone—CYP3A4—Prednisolone—multiple sclerosis	0.00138	0.0146	CbGbCtD
Triamcinolone—CYP3A4—Prednisone—multiple sclerosis	0.00131	0.0137	CbGbCtD
Triamcinolone—Flumethasone Pivalate—Methylprednisolone—multiple sclerosis	0.00129	0.00872	CrCrCtD
Triamcinolone—Flumethasone Pivalate—Betamethasone—multiple sclerosis	0.00127	0.00859	CrCrCtD
Triamcinolone—Flumethasone Pivalate—Dexamethasone—multiple sclerosis	0.00127	0.00859	CrCrCtD
Triamcinolone—Fluticasone Propionate—Methylprednisolone—multiple sclerosis	0.00125	0.00844	CrCrCtD
Triamcinolone—Difluprednate—Methylprednisolone—multiple sclerosis	0.00125	0.00844	CrCrCtD
Triamcinolone—Halobetasol Propionate—Methylprednisolone—multiple sclerosis	0.00125	0.00844	CrCrCtD
Triamcinolone—Halobetasol Propionate—Betamethasone—multiple sclerosis	0.00123	0.00831	CrCrCtD
Triamcinolone—Difluprednate—Betamethasone—multiple sclerosis	0.00123	0.00831	CrCrCtD
Triamcinolone—Difluprednate—Dexamethasone—multiple sclerosis	0.00123	0.00831	CrCrCtD
Triamcinolone—Halobetasol Propionate—Dexamethasone—multiple sclerosis	0.00123	0.00831	CrCrCtD
Triamcinolone—Fluticasone Propionate—Dexamethasone—multiple sclerosis	0.00123	0.00831	CrCrCtD
Triamcinolone—Fluticasone Propionate—Betamethasone—multiple sclerosis	0.00123	0.00831	CrCrCtD
Triamcinolone—Fluocinonide—Methylprednisolone—multiple sclerosis	0.00118	0.00794	CrCrCtD
Triamcinolone—Clocortolone—Methylprednisolone—multiple sclerosis	0.00118	0.00794	CrCrCtD
Triamcinolone—Testolactone—Methylprednisolone—multiple sclerosis	0.00118	0.00794	CrCrCtD
Triamcinolone—Prednicarbate—Methylprednisolone—multiple sclerosis	0.00118	0.00794	CrCrCtD
Triamcinolone—Prednicarbate—Betamethasone—multiple sclerosis	0.00116	0.00781	CrCrCtD
Triamcinolone—Testolactone—Betamethasone—multiple sclerosis	0.00116	0.00781	CrCrCtD
Triamcinolone—Prednicarbate—Dexamethasone—multiple sclerosis	0.00116	0.00781	CrCrCtD
Triamcinolone—Beclomethasone—Betamethasone—multiple sclerosis	0.00116	0.00781	CrCrCtD
Triamcinolone—Clocortolone—Dexamethasone—multiple sclerosis	0.00116	0.00781	CrCrCtD
Triamcinolone—Clocortolone—Betamethasone—multiple sclerosis	0.00116	0.00781	CrCrCtD
Triamcinolone—Beclomethasone—Dexamethasone—multiple sclerosis	0.00116	0.00781	CrCrCtD
Triamcinolone—Testolactone—Dexamethasone—multiple sclerosis	0.00116	0.00781	CrCrCtD
Triamcinolone—Fluocinonide—Betamethasone—multiple sclerosis	0.00116	0.00781	CrCrCtD
Triamcinolone—Fluocinonide—Dexamethasone—multiple sclerosis	0.00116	0.00781	CrCrCtD
Triamcinolone—Fluocortolone—Methylprednisolone—multiple sclerosis	0.00114	0.00771	CrCrCtD
Triamcinolone—Fluocortolone—Betamethasone—multiple sclerosis	0.00112	0.00759	CrCrCtD
Triamcinolone—Fluocortolone—Dexamethasone—multiple sclerosis	0.00112	0.00759	CrCrCtD
Triamcinolone—Fluocinolone Acetonide—Methylprednisolone—multiple sclerosis	0.00111	0.0075	CrCrCtD
Triamcinolone—Alclometasone—Methylprednisolone—multiple sclerosis	0.00111	0.0075	CrCrCtD
Triamcinolone—Alclometasone—Dexamethasone—multiple sclerosis	0.00109	0.00738	CrCrCtD
Triamcinolone—Alclometasone—Betamethasone—multiple sclerosis	0.00109	0.00738	CrCrCtD
Triamcinolone—Fluocinolone Acetonide—Dexamethasone—multiple sclerosis	0.00109	0.00738	CrCrCtD
Triamcinolone—Fluocinolone Acetonide—Betamethasone—multiple sclerosis	0.00109	0.00738	CrCrCtD
Triamcinolone—Budesonide—Methylprednisolone—multiple sclerosis	0.00108	0.0073	CrCrCtD
Triamcinolone—Testolactone—Prednisone—multiple sclerosis	0.00107	0.00725	CrCrCtD
Triamcinolone—Prednicarbate—Prednisone—multiple sclerosis	0.00107	0.00725	CrCrCtD
Triamcinolone—Amcinonide—Betamethasone—multiple sclerosis	0.00106	0.00718	CrCrCtD
Triamcinolone—Budesonide—Betamethasone—multiple sclerosis	0.00106	0.00718	CrCrCtD
Triamcinolone—Fluoxymesterone—Betamethasone—multiple sclerosis	0.00106	0.00718	CrCrCtD
Triamcinolone—Fluoxymesterone—Dexamethasone—multiple sclerosis	0.00106	0.00718	CrCrCtD
Triamcinolone—Budesonide—Dexamethasone—multiple sclerosis	0.00106	0.00718	CrCrCtD
Triamcinolone—Amcinonide—Dexamethasone—multiple sclerosis	0.00106	0.00718	CrCrCtD
Triamcinolone—Flunisolide—Methylprednisolone—multiple sclerosis	0.00105	0.00711	CrCrCtD
Triamcinolone—Diflorasone—Methylprednisolone—multiple sclerosis	0.00105	0.00711	CrCrCtD
Triamcinolone—Fludrocortisone—Methylprednisolone—multiple sclerosis	0.00105	0.00711	CrCrCtD
Triamcinolone—Desonide—Methylprednisolone—multiple sclerosis	0.00105	0.00711	CrCrCtD
Triamcinolone—Clobetasol propionate—Methylprednisolone—multiple sclerosis	0.00105	0.00711	CrCrCtD
Triamcinolone—Prednisone—Methylprednisolone—multiple sclerosis	0.00105	0.00711	CrCrCtD
Triamcinolone—Beclomethasone—Prednisolone—multiple sclerosis	0.00105	0.00707	CrCrCtD
Triamcinolone—Clocortolone—Prednisolone—multiple sclerosis	0.00105	0.00707	CrCrCtD
Triamcinolone—Prednicarbate—Prednisolone—multiple sclerosis	0.00105	0.00707	CrCrCtD
Triamcinolone—Testolactone—Prednisolone—multiple sclerosis	0.00105	0.00707	CrCrCtD
Triamcinolone—Fluocortolone—Prednisone—multiple sclerosis	0.00104	0.00704	CrCrCtD
Triamcinolone—Desonide—Dexamethasone—multiple sclerosis	0.00104	0.007	CrCrCtD
Triamcinolone—Desonide—Betamethasone—multiple sclerosis	0.00104	0.007	CrCrCtD
Triamcinolone—Fludrocortisone—Betamethasone—multiple sclerosis	0.00104	0.007	CrCrCtD
Triamcinolone—Diflorasone—Dexamethasone—multiple sclerosis	0.00104	0.007	CrCrCtD
Triamcinolone—Diflorasone—Betamethasone—multiple sclerosis	0.00104	0.007	CrCrCtD
Triamcinolone—Prednisone—Betamethasone—multiple sclerosis	0.00104	0.007	CrCrCtD
Triamcinolone—Clobetasol propionate—Betamethasone—multiple sclerosis	0.00104	0.007	CrCrCtD
Triamcinolone—Clobetasol propionate—Dexamethasone—multiple sclerosis	0.00104	0.007	CrCrCtD
Triamcinolone—Prednisone—Dexamethasone—multiple sclerosis	0.00104	0.007	CrCrCtD
Triamcinolone—Flunisolide—Betamethasone—multiple sclerosis	0.00104	0.007	CrCrCtD
Triamcinolone—Fludrocortisone—Dexamethasone—multiple sclerosis	0.00104	0.007	CrCrCtD
Triamcinolone—Flunisolide—Dexamethasone—multiple sclerosis	0.00104	0.007	CrCrCtD
Triamcinolone—Paramethasone—Methylprednisolone—multiple sclerosis	0.00103	0.00693	CrCrCtD
Triamcinolone—Fluocortolone—Prednisolone—multiple sclerosis	0.00102	0.00687	CrCrCtD
Triamcinolone—Alclometasone—Prednisone—multiple sclerosis	0.00101	0.00684	CrCrCtD
Triamcinolone—Paramethasone—Betamethasone—multiple sclerosis	0.00101	0.00682	CrCrCtD
Triamcinolone—Paramethasone—Dexamethasone—multiple sclerosis	0.00101	0.00682	CrCrCtD
Triamcinolone—Desoximetasone—Methylprednisolone—multiple sclerosis	0.001	0.00676	CrCrCtD
Triamcinolone—Alclometasone—Prednisolone—multiple sclerosis	0.000989	0.00668	CrCrCtD
Triamcinolone—Fluocinolone Acetonide—Prednisolone—multiple sclerosis	0.000989	0.00668	CrCrCtD
Triamcinolone—Amcinonide—Prednisone—multiple sclerosis	0.000986	0.00666	CrCrCtD
Triamcinolone—Budesonide—Prednisone—multiple sclerosis	0.000986	0.00666	CrCrCtD
Triamcinolone—Desoximetasone—Dexamethasone—multiple sclerosis	0.000985	0.00665	CrCrCtD
Triamcinolone—Desoximetasone—Betamethasone—multiple sclerosis	0.000985	0.00665	CrCrCtD
Triamcinolone—Fluorometholone—Methylprednisolone—multiple sclerosis	0.000978	0.0066	CrCrCtD
Triamcinolone—Fluprednidene Acetate—Methylprednisolone—multiple sclerosis	0.000978	0.0066	CrCrCtD
Triamcinolone—Mometasone—Methylprednisolone—multiple sclerosis	0.000978	0.0066	CrCrCtD
Triamcinolone—Loteprednol—Methylprednisolone—multiple sclerosis	0.000978	0.0066	CrCrCtD
Triamcinolone—Fluoxymesterone—Prednisolone—multiple sclerosis	0.000963	0.0065	CrCrCtD
Triamcinolone—Amcinonide—Prednisolone—multiple sclerosis	0.000963	0.0065	CrCrCtD
Triamcinolone—Budesonide—Prednisolone—multiple sclerosis	0.000963	0.0065	CrCrCtD
Triamcinolone—Fluprednidene Acetate—Dexamethasone—multiple sclerosis	0.000962	0.0065	CrCrCtD
Triamcinolone—Loteprednol—Dexamethasone—multiple sclerosis	0.000962	0.0065	CrCrCtD
Triamcinolone—Fluprednidene Acetate—Betamethasone—multiple sclerosis	0.000962	0.0065	CrCrCtD
Triamcinolone—Loteprednol—Betamethasone—multiple sclerosis	0.000962	0.0065	CrCrCtD
Triamcinolone—Fluorometholone—Betamethasone—multiple sclerosis	0.000962	0.0065	CrCrCtD
Triamcinolone—Fluorometholone—Dexamethasone—multiple sclerosis	0.000962	0.0065	CrCrCtD
Triamcinolone—Mometasone—Betamethasone—multiple sclerosis	0.000962	0.0065	CrCrCtD
Triamcinolone—Mometasone—Dexamethasone—multiple sclerosis	0.000962	0.0065	CrCrCtD
Triamcinolone—Desonide—Prednisone—multiple sclerosis	0.000961	0.00649	CrCrCtD
Triamcinolone—Flunisolide—Prednisone—multiple sclerosis	0.000961	0.00649	CrCrCtD
Triamcinolone—Fludrocortisone—Prednisone—multiple sclerosis	0.000961	0.00649	CrCrCtD
Triamcinolone—Diflorasone—Prednisone—multiple sclerosis	0.000961	0.00649	CrCrCtD
Triamcinolone—Clobetasol propionate—Prednisone—multiple sclerosis	0.000961	0.00649	CrCrCtD
Triamcinolone—Dexamethasone—Methylprednisolone—multiple sclerosis	0.000955	0.00645	CrCrCtD
Triamcinolone—Rimexolone—Methylprednisolone—multiple sclerosis	0.000955	0.00645	CrCrCtD
Triamcinolone—Betamethasone—Methylprednisolone—multiple sclerosis	0.000955	0.00645	CrCrCtD
Triamcinolone—Dexamethasone—Betamethasone—multiple sclerosis	0.00094	0.00635	CrCrCtD
Triamcinolone—Rimexolone—Betamethasone—multiple sclerosis	0.00094	0.00635	CrCrCtD
Triamcinolone—Rimexolone—Dexamethasone—multiple sclerosis	0.00094	0.00635	CrCrCtD
Triamcinolone—Betamethasone—Dexamethasone—multiple sclerosis	0.00094	0.00635	CrCrCtD
Triamcinolone—Flunisolide—Prednisolone—multiple sclerosis	0.000938	0.00633	CrCrCtD
Triamcinolone—Clobetasol propionate—Prednisolone—multiple sclerosis	0.000938	0.00633	CrCrCtD
Triamcinolone—Desonide—Prednisolone—multiple sclerosis	0.000938	0.00633	CrCrCtD
Triamcinolone—Prednisone—Prednisolone—multiple sclerosis	0.000938	0.00633	CrCrCtD
Triamcinolone—Diflorasone—Prednisolone—multiple sclerosis	0.000938	0.00633	CrCrCtD
Triamcinolone—Fludrocortisone—Prednisolone—multiple sclerosis	0.000938	0.00633	CrCrCtD
Triamcinolone—Paramethasone—Prednisone—multiple sclerosis	0.000936	0.00632	CrCrCtD
Triamcinolone—Paramethasone—Prednisolone—multiple sclerosis	0.000914	0.00617	CrCrCtD
Triamcinolone—Desoximetasone—Prednisone—multiple sclerosis	0.000914	0.00617	CrCrCtD
Triamcinolone—Methylprednisolone—Dexamethasone—multiple sclerosis	0.000899	0.00607	CrCrCtD
Triamcinolone—Methylprednisolone—Betamethasone—multiple sclerosis	0.000899	0.00607	CrCrCtD
Triamcinolone—Prednisolone—Methylprednisolone—multiple sclerosis	0.000894	0.00604	CrCrCtD
Triamcinolone—Mometasone—Prednisone—multiple sclerosis	0.000892	0.00603	CrCrCtD
Triamcinolone—Loteprednol—Prednisone—multiple sclerosis	0.000892	0.00603	CrCrCtD
Triamcinolone—Fluprednidene Acetate—Prednisone—multiple sclerosis	0.000892	0.00603	CrCrCtD
Triamcinolone—Fluorometholone—Prednisone—multiple sclerosis	0.000892	0.00603	CrCrCtD
Triamcinolone—Desoximetasone—Prednisolone—multiple sclerosis	0.000892	0.00602	CrCrCtD
Triamcinolone—Prednisolone—Betamethasone—multiple sclerosis	0.00088	0.00594	CrCrCtD
Triamcinolone—Prednisolone—Dexamethasone—multiple sclerosis	0.00088	0.00594	CrCrCtD
Triamcinolone—Dexamethasone—Prednisone—multiple sclerosis	0.000872	0.00589	CrCrCtD
Triamcinolone—Rimexolone—Prednisone—multiple sclerosis	0.000872	0.00589	CrCrCtD
Triamcinolone—Betamethasone—Prednisone—multiple sclerosis	0.000872	0.00589	CrCrCtD
Triamcinolone—Loteprednol—Prednisolone—multiple sclerosis	0.000871	0.00588	CrCrCtD
Triamcinolone—Fluorometholone—Prednisolone—multiple sclerosis	0.000871	0.00588	CrCrCtD
Triamcinolone—Mometasone—Prednisolone—multiple sclerosis	0.000871	0.00588	CrCrCtD
Triamcinolone—Fluprednidene Acetate—Prednisolone—multiple sclerosis	0.000871	0.00588	CrCrCtD
Triamcinolone—Hydrocortisone—Methylprednisolone—multiple sclerosis	0.000858	0.0058	CrCrCtD
Triamcinolone—Rimexolone—Prednisolone—multiple sclerosis	0.000851	0.00575	CrCrCtD
Triamcinolone—Betamethasone—Prednisolone—multiple sclerosis	0.000851	0.00575	CrCrCtD
Triamcinolone—Dexamethasone—Prednisolone—multiple sclerosis	0.000851	0.00575	CrCrCtD
Triamcinolone—Hydrocortisone—Dexamethasone—multiple sclerosis	0.000845	0.00571	CrCrCtD
Triamcinolone—Hydrocortisone—Betamethasone—multiple sclerosis	0.000845	0.00571	CrCrCtD
Triamcinolone—Methylprednisolone—Prednisone—multiple sclerosis	0.000834	0.00563	CrCrCtD
Triamcinolone—CYP3A4—Dexamethasone—multiple sclerosis	0.000816	0.00858	CbGbCtD
Triamcinolone—Prednisolone—Prednisone—multiple sclerosis	0.000816	0.00551	CrCrCtD
Triamcinolone—Methylprednisolone—Prednisolone—multiple sclerosis	0.000814	0.0055	CrCrCtD
Triamcinolone—Hydrocortisone—Prednisone—multiple sclerosis	0.000783	0.00529	CrCrCtD
Triamcinolone—Hydrocortisone—Prednisolone—multiple sclerosis	0.000765	0.00516	CrCrCtD
Triamcinolone—PTGS2—leg—multiple sclerosis	0.000118	0.149	CbGeAlD
Triamcinolone—PTGS2—Fluocinonide—Methylprednisolone—multiple sclerosis	0.000105	0.21	CbGdCrCtD
Triamcinolone—PTGS2—Fluocinonide—Betamethasone—multiple sclerosis	0.000103	0.207	CbGdCrCtD
Triamcinolone—PTGS2—Fluocinonide—Dexamethasone—multiple sclerosis	0.000103	0.207	CbGdCrCtD
Triamcinolone—NR3C1—nerve—multiple sclerosis	7.42e-05	0.0935	CbGeAlD
Triamcinolone—PTGS2—Fluticasone Propionate—Methylprednisolone—multiple sclerosis	6.33e-05	0.127	CbGdCrCtD
Triamcinolone—PTGS2—Fluticasone Propionate—Dexamethasone—multiple sclerosis	6.23e-05	0.125	CbGdCrCtD
Triamcinolone—PTGS2—Fluticasone Propionate—Betamethasone—multiple sclerosis	6.23e-05	0.125	CbGdCrCtD
Triamcinolone—PTGS2—S1P1 pathway—S1PR1—multiple sclerosis	5.71e-05	0.0465	CbGpPWpGaD
Triamcinolone—NR3C1—Endoderm Differentiation—HHEX—multiple sclerosis	5.03e-05	0.0409	CbGpPWpGaD
Triamcinolone—Fluticasone Propionate—PGR—multiple sclerosis	4.41e-05	0.366	CrCbGaD
Triamcinolone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTPRK—multiple sclerosis	4.34e-05	0.0354	CbGpPWpGaD
Triamcinolone—Betamethasone—PGR—multiple sclerosis	4.04e-05	0.335	CrCbGaD
Triamcinolone—SERPINA6—nervous system—multiple sclerosis	3.81e-05	0.048	CbGeAlD
Triamcinolone—SERPINA6—central nervous system—multiple sclerosis	3.67e-05	0.0462	CbGeAlD
Triamcinolone—SERPINA6—cerebellum—multiple sclerosis	3.59e-05	0.0452	CbGeAlD
Triamcinolone—BCHE—brainstem—multiple sclerosis	3.58e-05	0.0451	CbGeAlD
Triamcinolone—NR3C1—brainstem—multiple sclerosis	3.18e-05	0.0401	CbGeAlD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—PLP1—multiple sclerosis	3.04e-05	0.0248	CbGpPWpGaD
Triamcinolone—SERPINA6—brain—multiple sclerosis	2.91e-05	0.0367	CbGeAlD
Triamcinolone—NR3C1—Endoderm Differentiation—EOMES—multiple sclerosis	2.89e-05	0.0235	CbGpPWpGaD
Triamcinolone—NR3C1—Endoderm Differentiation—TBX21—multiple sclerosis	2.89e-05	0.0235	CbGpPWpGaD
Triamcinolone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TBX21—multiple sclerosis	2.8e-05	0.0228	CbGpPWpGaD
Triamcinolone—BCHE—medulla oblongata—multiple sclerosis	2.49e-05	0.0314	CbGeAlD
Triamcinolone—NR3C1—Glucocorticoid receptor regulatory network—TBX21—multiple sclerosis	2.49e-05	0.0202	CbGpPWpGaD
Triamcinolone—Dexamethasone—PGR—multiple sclerosis	2.35e-05	0.195	CrCbGaD
Triamcinolone—BCHE—midbrain—multiple sclerosis	2.28e-05	0.0287	CbGeAlD
Triamcinolone—BCHE—spinal cord—multiple sclerosis	2.22e-05	0.028	CbGeAlD
Triamcinolone—NR3C1—medulla oblongata—multiple sclerosis	2.22e-05	0.028	CbGeAlD
Triamcinolone—BCHE—Peptide hormone metabolism—SLC30A7—multiple sclerosis	2.17e-05	0.0177	CbGpPWpGaD
Triamcinolone—NR3C1—Nuclear Receptors—PGR—multiple sclerosis	2.15e-05	0.0175	CbGpPWpGaD
Triamcinolone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CBLB—multiple sclerosis	2.05e-05	0.0167	CbGpPWpGaD
Triamcinolone—NR3C1—midbrain—multiple sclerosis	2.03e-05	0.0256	CbGeAlD
Triamcinolone—PTGS2—Prostaglandin Synthesis and Regulation—PTGER4—multiple sclerosis	2e-05	0.0163	CbGpPWpGaD
Triamcinolone—NR3C1—spinal cord—multiple sclerosis	1.98e-05	0.025	CbGeAlD
Triamcinolone—PTGS2—medulla oblongata—multiple sclerosis	1.92e-05	0.0242	CbGeAlD
Triamcinolone—NR3C1—Endoderm Differentiation—PABPC1—multiple sclerosis	1.9e-05	0.0155	CbGpPWpGaD
Triamcinolone—BCHE—nervous system—multiple sclerosis	1.87e-05	0.0236	CbGeAlD
Triamcinolone—BCHE—central nervous system—multiple sclerosis	1.8e-05	0.0227	CbGeAlD
Triamcinolone—BCHE—cerebellum—multiple sclerosis	1.76e-05	0.0222	CbGeAlD
Triamcinolone—PTGS2—midbrain—multiple sclerosis	1.76e-05	0.0221	CbGeAlD
Triamcinolone—PTGS2—spinal cord—multiple sclerosis	1.71e-05	0.0216	CbGeAlD
Triamcinolone—NR3C1—Nuclear Receptor transcription pathway—PGR—multiple sclerosis	1.7e-05	0.0139	CbGpPWpGaD
Triamcinolone—NR3C1—nervous system—multiple sclerosis	1.67e-05	0.021	CbGeAlD
Triamcinolone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOXP3—multiple sclerosis	1.66e-05	0.0136	CbGpPWpGaD
Triamcinolone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	1.66e-05	0.0136	CbGpPWpGaD
Triamcinolone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	1.66e-05	0.0136	CbGpPWpGaD
Triamcinolone—NR3C1—central nervous system—multiple sclerosis	1.61e-05	0.0202	CbGeAlD
Triamcinolone—BCHE—Neuronal System—KCNA3—multiple sclerosis	1.6e-05	0.013	CbGpPWpGaD
Triamcinolone—NR3C1—cerebellum—multiple sclerosis	1.57e-05	0.0198	CbGeAlD
Triamcinolone—NR3C1—Nuclear Receptors—VDR—multiple sclerosis	1.51e-05	0.0123	CbGpPWpGaD
Triamcinolone—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	1.47e-05	0.012	CbGpPWpGaD
Triamcinolone—PTGS2—nervous system—multiple sclerosis	1.44e-05	0.0182	CbGeAlD
Triamcinolone—BCHE—brain—multiple sclerosis	1.43e-05	0.0181	CbGeAlD
Triamcinolone—NR3C1—Glucocorticoid receptor regulatory network—SELE—multiple sclerosis	1.43e-05	0.0116	CbGpPWpGaD
Triamcinolone—PTGS2—central nervous system—multiple sclerosis	1.39e-05	0.0175	CbGeAlD
Triamcinolone—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—multiple sclerosis	1.38e-05	0.0112	CbGpPWpGaD
Triamcinolone—PTGS2—cerebellum—multiple sclerosis	1.36e-05	0.0171	CbGeAlD
Triamcinolone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—multiple sclerosis	1.34e-05	0.0109	CbGpPWpGaD
Triamcinolone—Infection—Mitoxantrone—multiple sclerosis	1.31e-05	0.000296	CcSEcCtD
Triamcinolone—Shock—Mitoxantrone—multiple sclerosis	1.3e-05	0.000293	CcSEcCtD
Triamcinolone—Bradycardia—Betamethasone—multiple sclerosis	1.3e-05	0.000292	CcSEcCtD
Triamcinolone—Bradycardia—Dexamethasone—multiple sclerosis	1.3e-05	0.000292	CcSEcCtD
Triamcinolone—Body temperature increased—Azathioprine—multiple sclerosis	1.29e-05	0.000291	CcSEcCtD
Triamcinolone—Tachycardia—Mitoxantrone—multiple sclerosis	1.29e-05	0.000291	CcSEcCtD
Triamcinolone—Haemoglobin—Betamethasone—multiple sclerosis	1.28e-05	0.000289	CcSEcCtD
Triamcinolone—Haemoglobin—Dexamethasone—multiple sclerosis	1.28e-05	0.000289	CcSEcCtD
Triamcinolone—Vomiting—Cladribine—multiple sclerosis	1.28e-05	0.000288	CcSEcCtD
Triamcinolone—Hyperhidrosis—Mitoxantrone—multiple sclerosis	1.28e-05	0.000288	CcSEcCtD
Triamcinolone—NR3C1—brain—multiple sclerosis	1.28e-05	0.0161	CbGeAlD
Triamcinolone—Haemorrhage—Betamethasone—multiple sclerosis	1.27e-05	0.000287	CcSEcCtD
Triamcinolone—Haemorrhage—Dexamethasone—multiple sclerosis	1.27e-05	0.000287	CcSEcCtD
Triamcinolone—Mood swings—Methotrexate—multiple sclerosis	1.27e-05	0.000286	CcSEcCtD
Triamcinolone—Rash—Cladribine—multiple sclerosis	1.27e-05	0.000286	CcSEcCtD
Triamcinolone—Dermatitis—Cladribine—multiple sclerosis	1.27e-05	0.000286	CcSEcCtD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—C4A—multiple sclerosis	1.26e-05	0.0103	CbGpPWpGaD
Triamcinolone—CYP3A4—nervous system—multiple sclerosis	1.26e-05	0.0159	CbGeAlD
Triamcinolone—Weight increased—Prednisone—multiple sclerosis	1.26e-05	0.000284	CcSEcCtD
Triamcinolone—Headache—Cladribine—multiple sclerosis	1.26e-05	0.000284	CcSEcCtD
Triamcinolone—Prednisone—ALB—multiple sclerosis	1.26e-05	0.104	CrCbGaD
Triamcinolone—Arrhythmia—Methylprednisolone—multiple sclerosis	1.25e-05	0.000282	CcSEcCtD
Triamcinolone—Ill-defined disorder—Prednisolone—multiple sclerosis	1.23e-05	0.000278	CcSEcCtD
Triamcinolone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2RA—multiple sclerosis	1.23e-05	0.01	CbGpPWpGaD
Triamcinolone—Erythema—Methylprednisolone—multiple sclerosis	1.22e-05	0.000275	CcSEcCtD
Triamcinolone—Acute coronary syndrome—Prednisone—multiple sclerosis	1.22e-05	0.000275	CcSEcCtD
Triamcinolone—CYP3A4—central nervous system—multiple sclerosis	1.22e-05	0.0153	CbGeAlD
Triamcinolone—Angioedema—Prednisolone—multiple sclerosis	1.21e-05	0.000274	CcSEcCtD
Triamcinolone—Myocardial infarction—Prednisone—multiple sclerosis	1.21e-05	0.000273	CcSEcCtD
Triamcinolone—Neuropathy peripheral—Prednisone—multiple sclerosis	1.21e-05	0.000273	CcSEcCtD
Triamcinolone—Hypersensitivity—Azathioprine—multiple sclerosis	1.2e-05	0.000272	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	1.2e-05	0.000271	CcSEcCtD
Triamcinolone—PTGS2—Spinal Cord Injury—MBP—multiple sclerosis	1.2e-05	0.00975	CbGpPWpGaD
Triamcinolone—Malaise—Prednisolone—multiple sclerosis	1.2e-05	0.00027	CcSEcCtD
Triamcinolone—Nausea—Cladribine—multiple sclerosis	1.19e-05	0.000269	CcSEcCtD
Triamcinolone—Vertigo—Prednisolone—multiple sclerosis	1.19e-05	0.000269	CcSEcCtD
Triamcinolone—Syncope—Prednisolone—multiple sclerosis	1.19e-05	0.000269	CcSEcCtD
Triamcinolone—NR3C1—Nuclear Receptor transcription pathway—VDR—multiple sclerosis	1.19e-05	0.00968	CbGpPWpGaD
Triamcinolone—Paraesthesia—Mitoxantrone—multiple sclerosis	1.19e-05	0.000268	CcSEcCtD
Triamcinolone—Dyspnoea—Mitoxantrone—multiple sclerosis	1.18e-05	0.000266	CcSEcCtD
Triamcinolone—Loss of consciousness—Prednisolone—multiple sclerosis	1.17e-05	0.000263	CcSEcCtD
Triamcinolone—Dyspepsia—Mitoxantrone—multiple sclerosis	1.16e-05	0.000262	CcSEcCtD
Triamcinolone—Asthma—Methotrexate—multiple sclerosis	1.16e-05	0.000261	CcSEcCtD
Triamcinolone—Convulsion—Prednisolone—multiple sclerosis	1.15e-05	0.000259	CcSEcCtD
Triamcinolone—Hypertension—Prednisolone—multiple sclerosis	1.15e-05	0.000259	CcSEcCtD
Triamcinolone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—multiple sclerosis	1.15e-05	0.00933	CbGpPWpGaD
Triamcinolone—Fatigue—Mitoxantrone—multiple sclerosis	1.14e-05	0.000257	CcSEcCtD
Triamcinolone—Arrhythmia—Betamethasone—multiple sclerosis	1.14e-05	0.000256	CcSEcCtD
Triamcinolone—Arrhythmia—Dexamethasone—multiple sclerosis	1.14e-05	0.000256	CcSEcCtD
Triamcinolone—Pancreatitis—Methotrexate—multiple sclerosis	1.13e-05	0.000256	CcSEcCtD
Triamcinolone—Ill-defined disorder—Methylprednisolone—multiple sclerosis	1.13e-05	0.000255	CcSEcCtD
Triamcinolone—Pain—Mitoxantrone—multiple sclerosis	1.13e-05	0.000255	CcSEcCtD
Triamcinolone—Bradycardia—Prednisone—multiple sclerosis	1.13e-05	0.000255	CcSEcCtD
Triamcinolone—Discomfort—Prednisolone—multiple sclerosis	1.12e-05	0.000252	CcSEcCtD
Triamcinolone—Haemoglobin—Prednisone—multiple sclerosis	1.11e-05	0.000251	CcSEcCtD
Triamcinolone—Angioedema—Methylprednisolone—multiple sclerosis	1.11e-05	0.000251	CcSEcCtD
Triamcinolone—Haemorrhage—Prednisone—multiple sclerosis	1.11e-05	0.00025	CcSEcCtD
Triamcinolone—Erythema—Dexamethasone—multiple sclerosis	1.11e-05	0.00025	CcSEcCtD
Triamcinolone—Erythema—Betamethasone—multiple sclerosis	1.11e-05	0.00025	CcSEcCtD
Triamcinolone—PTGS2—brain—multiple sclerosis	1.1e-05	0.0139	CbGeAlD
Triamcinolone—Malaise—Methylprednisolone—multiple sclerosis	1.1e-05	0.000248	CcSEcCtD
Triamcinolone—Vertigo—Methylprednisolone—multiple sclerosis	1.09e-05	0.000247	CcSEcCtD
Triamcinolone—Syncope—Methylprednisolone—multiple sclerosis	1.09e-05	0.000246	CcSEcCtD
Triamcinolone—Feeling abnormal—Mitoxantrone—multiple sclerosis	1.09e-05	0.000246	CcSEcCtD
Triamcinolone—Anaphylactic shock—Prednisolone—multiple sclerosis	1.08e-05	0.000244	CcSEcCtD
Triamcinolone—Oedema—Prednisolone—multiple sclerosis	1.08e-05	0.000244	CcSEcCtD
Triamcinolone—Dizziness—Azathioprine—multiple sclerosis	1.08e-05	0.000244	CcSEcCtD
Triamcinolone—Upper respiratory tract infection—Methotrexate—multiple sclerosis	1.08e-05	0.000243	CcSEcCtD
Triamcinolone—Loss of consciousness—Methylprednisolone—multiple sclerosis	1.07e-05	0.000242	CcSEcCtD
Triamcinolone—Shock—Prednisolone—multiple sclerosis	1.07e-05	0.00024	CcSEcCtD
Triamcinolone—Tachycardia—Prednisolone—multiple sclerosis	1.06e-05	0.000239	CcSEcCtD
Triamcinolone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	1.06e-05	0.0086	CbGpPWpGaD
Triamcinolone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	1.06e-05	0.0086	CbGpPWpGaD
Triamcinolone—Convulsion—Methylprednisolone—multiple sclerosis	1.06e-05	0.000238	CcSEcCtD
Triamcinolone—Hypertension—Methylprednisolone—multiple sclerosis	1.05e-05	0.000237	CcSEcCtD
Triamcinolone—Urticaria—Mitoxantrone—multiple sclerosis	1.05e-05	0.000237	CcSEcCtD
Triamcinolone—Hyperhidrosis—Prednisolone—multiple sclerosis	1.05e-05	0.000236	CcSEcCtD
Triamcinolone—Body temperature increased—Mitoxantrone—multiple sclerosis	1.04e-05	0.000236	CcSEcCtD
Triamcinolone—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	1.04e-05	0.00849	CbGpPWpGaD
Triamcinolone—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	1.04e-05	0.00849	CbGpPWpGaD
Triamcinolone—Vomiting—Azathioprine—multiple sclerosis	1.04e-05	0.000234	CcSEcCtD
Triamcinolone—Myalgia—Methylprednisolone—multiple sclerosis	1.04e-05	0.000234	CcSEcCtD
Triamcinolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IFNB1—multiple sclerosis	1.03e-05	0.00843	CbGpPWpGaD
Triamcinolone—Rash—Azathioprine—multiple sclerosis	1.03e-05	0.000232	CcSEcCtD
Triamcinolone—Dermatitis—Azathioprine—multiple sclerosis	1.03e-05	0.000232	CcSEcCtD
Triamcinolone—Ill-defined disorder—Betamethasone—multiple sclerosis	1.03e-05	0.000232	CcSEcCtD
Triamcinolone—Ill-defined disorder—Dexamethasone—multiple sclerosis	1.03e-05	0.000232	CcSEcCtD
Triamcinolone—Discomfort—Methylprednisolone—multiple sclerosis	1.02e-05	0.000231	CcSEcCtD
Triamcinolone—Headache—Azathioprine—multiple sclerosis	1.02e-05	0.000231	CcSEcCtD
Triamcinolone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK1—multiple sclerosis	1.02e-05	0.0083	CbGpPWpGaD
Triamcinolone—Angioedema—Dexamethasone—multiple sclerosis	1.01e-05	0.000228	CcSEcCtD
Triamcinolone—Angioedema—Betamethasone—multiple sclerosis	1.01e-05	0.000228	CcSEcCtD
Triamcinolone—Conjunctivitis—Methotrexate—multiple sclerosis	1e-05	0.000226	CcSEcCtD
Triamcinolone—Malaise—Dexamethasone—multiple sclerosis	9.99e-06	0.000225	CcSEcCtD
Triamcinolone—Malaise—Betamethasone—multiple sclerosis	9.99e-06	0.000225	CcSEcCtD
Triamcinolone—Vertigo—Betamethasone—multiple sclerosis	9.95e-06	0.000225	CcSEcCtD
Triamcinolone—Vertigo—Dexamethasone—multiple sclerosis	9.95e-06	0.000225	CcSEcCtD
Triamcinolone—Anaphylactic shock—Methylprednisolone—multiple sclerosis	9.94e-06	0.000224	CcSEcCtD
Triamcinolone—Syncope—Dexamethasone—multiple sclerosis	9.93e-06	0.000224	CcSEcCtD
Triamcinolone—Syncope—Betamethasone—multiple sclerosis	9.93e-06	0.000224	CcSEcCtD
Triamcinolone—Arrhythmia—Prednisone—multiple sclerosis	9.9e-06	0.000223	CcSEcCtD
Triamcinolone—Infection—Methylprednisolone—multiple sclerosis	9.88e-06	0.000223	CcSEcCtD
Triamcinolone—Insomnia—Prednisolone—multiple sclerosis	9.8e-06	0.000221	CcSEcCtD
Triamcinolone—Shock—Methylprednisolone—multiple sclerosis	9.78e-06	0.000221	CcSEcCtD
Triamcinolone—NR3C1—Generic Transcription Pathway—ZNF746—multiple sclerosis	9.74e-06	0.00793	CbGpPWpGaD
Triamcinolone—Loss of consciousness—Betamethasone—multiple sclerosis	9.74e-06	0.00022	CcSEcCtD
Triamcinolone—Loss of consciousness—Dexamethasone—multiple sclerosis	9.74e-06	0.00022	CcSEcCtD
Triamcinolone—Epistaxis—Methotrexate—multiple sclerosis	9.73e-06	0.00022	CcSEcCtD
Triamcinolone—Hypersensitivity—Mitoxantrone—multiple sclerosis	9.73e-06	0.000219	CcSEcCtD
Triamcinolone—Paraesthesia—Prednisolone—multiple sclerosis	9.73e-06	0.000219	CcSEcCtD
Triamcinolone—Nausea—Azathioprine—multiple sclerosis	9.7e-06	0.000219	CcSEcCtD
Triamcinolone—Tachycardia—Methylprednisolone—multiple sclerosis	9.7e-06	0.000219	CcSEcCtD
Triamcinolone—Erythema—Prednisone—multiple sclerosis	9.65e-06	0.000218	CcSEcCtD
Triamcinolone—Hyperhidrosis—Methylprednisolone—multiple sclerosis	9.61e-06	0.000217	CcSEcCtD
Triamcinolone—Convulsion—Betamethasone—multiple sclerosis	9.6e-06	0.000217	CcSEcCtD
Triamcinolone—Convulsion—Dexamethasone—multiple sclerosis	9.6e-06	0.000217	CcSEcCtD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	9.58e-06	0.0078	CbGpPWpGaD
Triamcinolone—Hypertension—Dexamethasone—multiple sclerosis	9.56e-06	0.000216	CcSEcCtD
Triamcinolone—Hypertension—Betamethasone—multiple sclerosis	9.56e-06	0.000216	CcSEcCtD
Triamcinolone—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	9.48e-06	0.00772	CbGpPWpGaD
Triamcinolone—Asthenia—Mitoxantrone—multiple sclerosis	9.47e-06	0.000214	CcSEcCtD
Triamcinolone—Myalgia—Dexamethasone—multiple sclerosis	9.43e-06	0.000213	CcSEcCtD
Triamcinolone—Myalgia—Betamethasone—multiple sclerosis	9.43e-06	0.000213	CcSEcCtD
Triamcinolone—Discomfort—Dexamethasone—multiple sclerosis	9.32e-06	0.00021	CcSEcCtD
Triamcinolone—Discomfort—Betamethasone—multiple sclerosis	9.32e-06	0.00021	CcSEcCtD
Triamcinolone—Haemoglobin—Methotrexate—multiple sclerosis	9.31e-06	0.00021	CcSEcCtD
Triamcinolone—Pain—Prednisolone—multiple sclerosis	9.26e-06	0.000209	CcSEcCtD
Triamcinolone—Haemorrhage—Methotrexate—multiple sclerosis	9.26e-06	0.000209	CcSEcCtD
Triamcinolone—Pharyngitis—Methotrexate—multiple sclerosis	9.19e-06	0.000207	CcSEcCtD
Triamcinolone—PTGS2—Spinal Cord Injury—AQP4—multiple sclerosis	9.07e-06	0.00739	CbGpPWpGaD
Triamcinolone—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	9.06e-06	0.000204	CcSEcCtD
Triamcinolone—Oedema—Betamethasone—multiple sclerosis	9.04e-06	0.000204	CcSEcCtD
Triamcinolone—Anaphylactic shock—Betamethasone—multiple sclerosis	9.04e-06	0.000204	CcSEcCtD
Triamcinolone—Oedema—Dexamethasone—multiple sclerosis	9.04e-06	0.000204	CcSEcCtD
Triamcinolone—Anaphylactic shock—Dexamethasone—multiple sclerosis	9.04e-06	0.000204	CcSEcCtD
Triamcinolone—Insomnia—Methylprednisolone—multiple sclerosis	8.99e-06	0.000203	CcSEcCtD
Triamcinolone—NR3C1—AP-1 transcription factor network—IL10—multiple sclerosis	8.98e-06	0.00731	CbGpPWpGaD
Triamcinolone—Infection—Dexamethasone—multiple sclerosis	8.98e-06	0.000203	CcSEcCtD
Triamcinolone—Infection—Betamethasone—multiple sclerosis	8.98e-06	0.000203	CcSEcCtD
Triamcinolone—Ill-defined disorder—Prednisone—multiple sclerosis	8.95e-06	0.000202	CcSEcCtD
Triamcinolone—Feeling abnormal—Prednisolone—multiple sclerosis	8.93e-06	0.000201	CcSEcCtD
Triamcinolone—Paraesthesia—Methylprednisolone—multiple sclerosis	8.93e-06	0.000201	CcSEcCtD
Triamcinolone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—multiple sclerosis	8.91e-06	0.00725	CbGpPWpGaD
Triamcinolone—Shock—Dexamethasone—multiple sclerosis	8.89e-06	0.000201	CcSEcCtD
Triamcinolone—Shock—Betamethasone—multiple sclerosis	8.89e-06	0.000201	CcSEcCtD
Triamcinolone—Tachycardia—Dexamethasone—multiple sclerosis	8.82e-06	0.000199	CcSEcCtD
Triamcinolone—Tachycardia—Betamethasone—multiple sclerosis	8.82e-06	0.000199	CcSEcCtD
Triamcinolone—Angioedema—Prednisone—multiple sclerosis	8.81e-06	0.000199	CcSEcCtD
Triamcinolone—Dyspepsia—Methylprednisolone—multiple sclerosis	8.75e-06	0.000197	CcSEcCtD
Triamcinolone—Hyperhidrosis—Dexamethasone—multiple sclerosis	8.74e-06	0.000197	CcSEcCtD
Triamcinolone—Hyperhidrosis—Betamethasone—multiple sclerosis	8.74e-06	0.000197	CcSEcCtD
Triamcinolone—NR3C1—AP-1 transcription factor network—IL4—multiple sclerosis	8.74e-06	0.00711	CbGpPWpGaD
Triamcinolone—Malaise—Prednisone—multiple sclerosis	8.7e-06	0.000196	CcSEcCtD
Triamcinolone—Vertigo—Prednisone—multiple sclerosis	8.67e-06	0.000196	CcSEcCtD
Triamcinolone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—multiple sclerosis	8.67e-06	0.00706	CbGpPWpGaD
Triamcinolone—Syncope—Prednisone—multiple sclerosis	8.65e-06	0.000195	CcSEcCtD
Triamcinolone—NR3C1—Transcription factor regulation in adipogenesis—TNF—multiple sclerosis	8.63e-06	0.00703	CbGpPWpGaD
Triamcinolone—Urticaria—Prednisolone—multiple sclerosis	8.61e-06	0.000194	CcSEcCtD
Triamcinolone—Fatigue—Methylprednisolone—multiple sclerosis	8.57e-06	0.000193	CcSEcCtD
Triamcinolone—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	8.57e-06	0.00697	CbGpPWpGaD
Triamcinolone—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	8.57e-06	0.00697	CbGpPWpGaD
Triamcinolone—Loss of consciousness—Prednisone—multiple sclerosis	8.48e-06	0.000191	CcSEcCtD
Triamcinolone—Vomiting—Mitoxantrone—multiple sclerosis	8.4e-06	0.000189	CcSEcCtD
Triamcinolone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—multiple sclerosis	8.39e-06	0.00683	CbGpPWpGaD
Triamcinolone—Convulsion—Prednisone—multiple sclerosis	8.36e-06	0.000189	CcSEcCtD
Triamcinolone—Hypertension—Prednisone—multiple sclerosis	8.33e-06	0.000188	CcSEcCtD
Triamcinolone—Rash—Mitoxantrone—multiple sclerosis	8.33e-06	0.000188	CcSEcCtD
Triamcinolone—Dermatitis—Mitoxantrone—multiple sclerosis	8.32e-06	0.000188	CcSEcCtD
Triamcinolone—Headache—Mitoxantrone—multiple sclerosis	8.27e-06	0.000187	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	8.24e-06	0.000186	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	8.24e-06	0.000186	CcSEcCtD
Triamcinolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—multiple sclerosis	8.21e-06	0.00669	CbGpPWpGaD
Triamcinolone—Myalgia—Prednisone—multiple sclerosis	8.21e-06	0.000185	CcSEcCtD
Triamcinolone—Feeling abnormal—Methylprednisolone—multiple sclerosis	8.19e-06	0.000185	CcSEcCtD
Triamcinolone—Insomnia—Dexamethasone—multiple sclerosis	8.18e-06	0.000184	CcSEcCtD
Triamcinolone—Insomnia—Betamethasone—multiple sclerosis	8.18e-06	0.000184	CcSEcCtD
Triamcinolone—Paraesthesia—Betamethasone—multiple sclerosis	8.12e-06	0.000183	CcSEcCtD
Triamcinolone—Paraesthesia—Dexamethasone—multiple sclerosis	8.12e-06	0.000183	CcSEcCtD
Triamcinolone—Discomfort—Prednisone—multiple sclerosis	8.11e-06	0.000183	CcSEcCtD
Triamcinolone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—multiple sclerosis	8.1e-06	0.0066	CbGpPWpGaD
Triamcinolone—Erythema—Methotrexate—multiple sclerosis	8.06e-06	0.000182	CcSEcCtD
Triamcinolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—multiple sclerosis	7.99e-06	0.00651	CbGpPWpGaD
Triamcinolone—Hypersensitivity—Prednisolone—multiple sclerosis	7.98e-06	0.00018	CcSEcCtD
Triamcinolone—Dyspepsia—Betamethasone—multiple sclerosis	7.96e-06	0.00018	CcSEcCtD
Triamcinolone—Dyspepsia—Dexamethasone—multiple sclerosis	7.96e-06	0.00018	CcSEcCtD
Triamcinolone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—multiple sclerosis	7.94e-06	0.00647	CbGpPWpGaD
Triamcinolone—NR3C1—AP-1 transcription factor network—HLA-A—multiple sclerosis	7.91e-06	0.00644	CbGpPWpGaD
Triamcinolone—Urticaria—Methylprednisolone—multiple sclerosis	7.9e-06	0.000178	CcSEcCtD
Triamcinolone—Dysgeusia—Methotrexate—multiple sclerosis	7.89e-06	0.000178	CcSEcCtD
Triamcinolone—Oedema—Prednisone—multiple sclerosis	7.87e-06	0.000178	CcSEcCtD
Triamcinolone—Anaphylactic shock—Prednisone—multiple sclerosis	7.87e-06	0.000178	CcSEcCtD
Triamcinolone—Nausea—Mitoxantrone—multiple sclerosis	7.84e-06	0.000177	CcSEcCtD
Triamcinolone—Infection—Prednisone—multiple sclerosis	7.82e-06	0.000176	CcSEcCtD
Triamcinolone—Back pain—Methotrexate—multiple sclerosis	7.8e-06	0.000176	CcSEcCtD
Triamcinolone—Fatigue—Dexamethasone—multiple sclerosis	7.79e-06	0.000176	CcSEcCtD
Triamcinolone—Fatigue—Betamethasone—multiple sclerosis	7.79e-06	0.000176	CcSEcCtD
Triamcinolone—Shock—Prednisone—multiple sclerosis	7.75e-06	0.000175	CcSEcCtD
Triamcinolone—Pain—Dexamethasone—multiple sclerosis	7.73e-06	0.000174	CcSEcCtD
Triamcinolone—Pain—Betamethasone—multiple sclerosis	7.73e-06	0.000174	CcSEcCtD
Triamcinolone—PTGS2—S1P1 pathway—MAPK1—multiple sclerosis	7.72e-06	0.00629	CbGpPWpGaD
Triamcinolone—NR3C1—Glucocorticoid receptor regulatory network—IL4—multiple sclerosis	7.7e-06	0.00627	CbGpPWpGaD
Triamcinolone—Tachycardia—Prednisone—multiple sclerosis	7.68e-06	0.000173	CcSEcCtD
Triamcinolone—Hyperhidrosis—Prednisone—multiple sclerosis	7.61e-06	0.000172	CcSEcCtD
Triamcinolone—Ill-defined disorder—Methotrexate—multiple sclerosis	7.48e-06	0.000169	CcSEcCtD
Triamcinolone—Feeling abnormal—Dexamethasone—multiple sclerosis	7.45e-06	0.000168	CcSEcCtD
Triamcinolone—Feeling abnormal—Betamethasone—multiple sclerosis	7.45e-06	0.000168	CcSEcCtD
Triamcinolone—PTGS2—Overview of nanoparticle effects—TNF—multiple sclerosis	7.35e-06	0.00599	CbGpPWpGaD
Triamcinolone—Hypersensitivity—Methylprednisolone—multiple sclerosis	7.32e-06	0.000165	CcSEcCtD
Triamcinolone—Malaise—Methotrexate—multiple sclerosis	7.27e-06	0.000164	CcSEcCtD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	7.26e-06	0.00591	CbGpPWpGaD
Triamcinolone—Vertigo—Methotrexate—multiple sclerosis	7.24e-06	0.000163	CcSEcCtD
Triamcinolone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—multiple sclerosis	7.2e-06	0.00586	CbGpPWpGaD
Triamcinolone—Urticaria—Betamethasone—multiple sclerosis	7.18e-06	0.000162	CcSEcCtD
Triamcinolone—Urticaria—Dexamethasone—multiple sclerosis	7.18e-06	0.000162	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Prednisone—multiple sclerosis	7.17e-06	0.000162	CcSEcCtD
Triamcinolone—Dizziness—Prednisolone—multiple sclerosis	7.16e-06	0.000162	CcSEcCtD
Triamcinolone—Body temperature increased—Betamethasone—multiple sclerosis	7.15e-06	0.000161	CcSEcCtD
Triamcinolone—Body temperature increased—Dexamethasone—multiple sclerosis	7.15e-06	0.000161	CcSEcCtD
Triamcinolone—Asthenia—Methylprednisolone—multiple sclerosis	7.13e-06	0.000161	CcSEcCtD
Triamcinolone—Insomnia—Prednisone—multiple sclerosis	7.12e-06	0.000161	CcSEcCtD
Triamcinolone—Paraesthesia—Prednisone—multiple sclerosis	7.07e-06	0.000159	CcSEcCtD
Triamcinolone—Cough—Methotrexate—multiple sclerosis	7.03e-06	0.000159	CcSEcCtD
Triamcinolone—Pruritus—Methylprednisolone—multiple sclerosis	7.03e-06	0.000159	CcSEcCtD
Triamcinolone—Convulsion—Methotrexate—multiple sclerosis	6.98e-06	0.000158	CcSEcCtD
Triamcinolone—NR3C1—Transcription factor regulation in adipogenesis—IL6—multiple sclerosis	6.96e-06	0.00567	CbGpPWpGaD
Triamcinolone—Dyspepsia—Prednisone—multiple sclerosis	6.93e-06	0.000156	CcSEcCtD
Triamcinolone—Myalgia—Methotrexate—multiple sclerosis	6.86e-06	0.000155	CcSEcCtD
Triamcinolone—Rash—Prednisolone—multiple sclerosis	6.83e-06	0.000154	CcSEcCtD
Triamcinolone—Dermatitis—Prednisolone—multiple sclerosis	6.82e-06	0.000154	CcSEcCtD
Triamcinolone—Fatigue—Prednisone—multiple sclerosis	6.79e-06	0.000153	CcSEcCtD
Triamcinolone—Headache—Prednisolone—multiple sclerosis	6.79e-06	0.000153	CcSEcCtD
Triamcinolone—Discomfort—Methotrexate—multiple sclerosis	6.78e-06	0.000153	CcSEcCtD
Triamcinolone—Anaphylactic shock—Methotrexate—multiple sclerosis	6.58e-06	0.000148	CcSEcCtD
Triamcinolone—Dizziness—Methylprednisolone—multiple sclerosis	6.57e-06	0.000148	CcSEcCtD
Triamcinolone—Infection—Methotrexate—multiple sclerosis	6.54e-06	0.000147	CcSEcCtD
Triamcinolone—Feeling abnormal—Prednisone—multiple sclerosis	6.49e-06	0.000146	CcSEcCtD
Triamcinolone—Asthenia—Betamethasone—multiple sclerosis	6.49e-06	0.000146	CcSEcCtD
Triamcinolone—Asthenia—Dexamethasone—multiple sclerosis	6.49e-06	0.000146	CcSEcCtD
Triamcinolone—Nausea—Prednisolone—multiple sclerosis	6.44e-06	0.000145	CcSEcCtD
Triamcinolone—Pruritus—Betamethasone—multiple sclerosis	6.4e-06	0.000144	CcSEcCtD
Triamcinolone—Pruritus—Dexamethasone—multiple sclerosis	6.4e-06	0.000144	CcSEcCtD
Triamcinolone—Hyperhidrosis—Methotrexate—multiple sclerosis	6.36e-06	0.000143	CcSEcCtD
Triamcinolone—Vomiting—Methylprednisolone—multiple sclerosis	6.32e-06	0.000143	CcSEcCtD
Triamcinolone—PTGS2—Spinal Cord Injury—CCR2—multiple sclerosis	6.29e-06	0.00512	CbGpPWpGaD
Triamcinolone—Rash—Methylprednisolone—multiple sclerosis	6.27e-06	0.000141	CcSEcCtD
Triamcinolone—Dermatitis—Methylprednisolone—multiple sclerosis	6.26e-06	0.000141	CcSEcCtD
Triamcinolone—Urticaria—Prednisone—multiple sclerosis	6.25e-06	0.000141	CcSEcCtD
Triamcinolone—Headache—Methylprednisolone—multiple sclerosis	6.23e-06	0.00014	CcSEcCtD
Triamcinolone—Body temperature increased—Prednisone—multiple sclerosis	6.22e-06	0.00014	CcSEcCtD
Triamcinolone—NR3C1—AP-1 transcription factor network—CCL2—multiple sclerosis	6.21e-06	0.00506	CbGpPWpGaD
Triamcinolone—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—multiple sclerosis	6.12e-06	0.00498	CbGpPWpGaD
Triamcinolone—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	5.99e-06	0.000135	CcSEcCtD
Triamcinolone—BCHE—Peptide hormone metabolism—POMC—multiple sclerosis	5.98e-06	0.00487	CbGpPWpGaD
Triamcinolone—Dizziness—Betamethasone—multiple sclerosis	5.98e-06	0.000135	CcSEcCtD
Triamcinolone—Dizziness—Dexamethasone—multiple sclerosis	5.98e-06	0.000135	CcSEcCtD
Triamcinolone—Insomnia—Methotrexate—multiple sclerosis	5.95e-06	0.000134	CcSEcCtD
Triamcinolone—PTGS2—Overview of nanoparticle effects—IL6—multiple sclerosis	5.93e-06	0.00483	CbGpPWpGaD
Triamcinolone—Paraesthesia—Methotrexate—multiple sclerosis	5.91e-06	0.000133	CcSEcCtD
Triamcinolone—Nausea—Methylprednisolone—multiple sclerosis	5.9e-06	0.000133	CcSEcCtD
Triamcinolone—Dyspnoea—Methotrexate—multiple sclerosis	5.87e-06	0.000132	CcSEcCtD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	5.81e-06	0.00473	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	5.81e-06	0.00473	CbGpPWpGaD
Triamcinolone—Hypersensitivity—Prednisone—multiple sclerosis	5.8e-06	0.000131	CcSEcCtD
Triamcinolone—Dyspepsia—Methotrexate—multiple sclerosis	5.79e-06	0.000131	CcSEcCtD
Triamcinolone—Vomiting—Dexamethasone—multiple sclerosis	5.75e-06	0.00013	CcSEcCtD
Triamcinolone—Vomiting—Betamethasone—multiple sclerosis	5.75e-06	0.00013	CcSEcCtD
Triamcinolone—Rash—Betamethasone—multiple sclerosis	5.7e-06	0.000129	CcSEcCtD
Triamcinolone—Rash—Dexamethasone—multiple sclerosis	5.7e-06	0.000129	CcSEcCtD
Triamcinolone—Dermatitis—Betamethasone—multiple sclerosis	5.69e-06	0.000128	CcSEcCtD
Triamcinolone—Dermatitis—Dexamethasone—multiple sclerosis	5.69e-06	0.000128	CcSEcCtD
Triamcinolone—Fatigue—Methotrexate—multiple sclerosis	5.67e-06	0.000128	CcSEcCtD
Triamcinolone—Headache—Betamethasone—multiple sclerosis	5.66e-06	0.000128	CcSEcCtD
Triamcinolone—Headache—Dexamethasone—multiple sclerosis	5.66e-06	0.000128	CcSEcCtD
Triamcinolone—Asthenia—Prednisone—multiple sclerosis	5.65e-06	0.000127	CcSEcCtD
Triamcinolone—Pain—Methotrexate—multiple sclerosis	5.63e-06	0.000127	CcSEcCtD
Triamcinolone—NR3C1—Glucocorticoid receptor regulatory network—POMC—multiple sclerosis	5.59e-06	0.00455	CbGpPWpGaD
Triamcinolone—Pruritus—Prednisone—multiple sclerosis	5.57e-06	0.000126	CcSEcCtD
Triamcinolone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	5.45e-06	0.00443	CbGpPWpGaD
Triamcinolone—Feeling abnormal—Methotrexate—multiple sclerosis	5.42e-06	0.000122	CcSEcCtD
Triamcinolone—Nausea—Dexamethasone—multiple sclerosis	5.37e-06	0.000121	CcSEcCtD
Triamcinolone—Nausea—Betamethasone—multiple sclerosis	5.37e-06	0.000121	CcSEcCtD
Triamcinolone—NR3C1—AP-1 transcription factor network—IFNG—multiple sclerosis	5.28e-06	0.0043	CbGpPWpGaD
Triamcinolone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—multiple sclerosis	5.24e-06	0.00427	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—CXCL10—multiple sclerosis	5.23e-06	0.00426	CbGpPWpGaD
Triamcinolone—Urticaria—Methotrexate—multiple sclerosis	5.23e-06	0.000118	CcSEcCtD
Triamcinolone—Dizziness—Prednisone—multiple sclerosis	5.21e-06	0.000117	CcSEcCtD
Triamcinolone—Body temperature increased—Methotrexate—multiple sclerosis	5.2e-06	0.000117	CcSEcCtD
Triamcinolone—Vomiting—Prednisone—multiple sclerosis	5.01e-06	0.000113	CcSEcCtD
Triamcinolone—Rash—Prednisone—multiple sclerosis	4.96e-06	0.000112	CcSEcCtD
Triamcinolone—Dermatitis—Prednisone—multiple sclerosis	4.96e-06	0.000112	CcSEcCtD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	4.96e-06	0.00403	CbGpPWpGaD
Triamcinolone—Headache—Prednisone—multiple sclerosis	4.93e-06	0.000111	CcSEcCtD
Triamcinolone—NR3C1—Adipogenesis—FAS—multiple sclerosis	4.91e-06	0.004	CbGpPWpGaD
Triamcinolone—Hypersensitivity—Methotrexate—multiple sclerosis	4.85e-06	0.000109	CcSEcCtD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—IL10—multiple sclerosis	4.73e-06	0.00385	CbGpPWpGaD
Triamcinolone—Asthenia—Methotrexate—multiple sclerosis	4.72e-06	0.000106	CcSEcCtD
Triamcinolone—PTGS2—Spinal Cord Injury—BDNF—multiple sclerosis	4.69e-06	0.00382	CbGpPWpGaD
Triamcinolone—NR3C1—AP-1 transcription factor network—IL2—multiple sclerosis	4.69e-06	0.00382	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—ZNF746—multiple sclerosis	4.69e-06	0.00382	CbGpPWpGaD
Triamcinolone—Nausea—Prednisone—multiple sclerosis	4.68e-06	0.000105	CcSEcCtD
Triamcinolone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—multiple sclerosis	4.65e-06	0.00379	CbGpPWpGaD
Triamcinolone—Pruritus—Methotrexate—multiple sclerosis	4.65e-06	0.000105	CcSEcCtD
Triamcinolone—NR3C1—Glucocorticoid receptor regulatory network—IFNG—multiple sclerosis	4.65e-06	0.00379	CbGpPWpGaD
Triamcinolone—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	4.55e-06	0.0037	CbGpPWpGaD
Triamcinolone—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	4.55e-06	0.0037	CbGpPWpGaD
Triamcinolone—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	4.49e-06	0.00365	CbGpPWpGaD
Triamcinolone—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	4.49e-06	0.00365	CbGpPWpGaD
Triamcinolone—NR3C1—AP-1 transcription factor network—MMP9—multiple sclerosis	4.44e-06	0.00362	CbGpPWpGaD
Triamcinolone—PTGS2—Selenium Micronutrient Network—ICAM1—multiple sclerosis	4.38e-06	0.00357	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—IL4—multiple sclerosis	4.36e-06	0.00355	CbGpPWpGaD
Triamcinolone—Dizziness—Methotrexate—multiple sclerosis	4.35e-06	9.82e-05	CcSEcCtD
Triamcinolone—NR3C1—Gene Expression—PTBP1—multiple sclerosis	4.29e-06	0.00349	CbGpPWpGaD
Triamcinolone—Vomiting—Methotrexate—multiple sclerosis	4.18e-06	9.44e-05	CcSEcCtD
Triamcinolone—Rash—Methotrexate—multiple sclerosis	4.15e-06	9.36e-05	CcSEcCtD
Triamcinolone—Dermatitis—Methotrexate—multiple sclerosis	4.14e-06	9.35e-05	CcSEcCtD
Triamcinolone—NR3C1—Glucocorticoid receptor regulatory network—IL2—multiple sclerosis	4.13e-06	0.00337	CbGpPWpGaD
Triamcinolone—Headache—Methotrexate—multiple sclerosis	4.12e-06	9.3e-05	CcSEcCtD
Triamcinolone—BCHE—Metabolism of proteins—SLC30A7—multiple sclerosis	4.09e-06	0.00333	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	4e-06	0.00326	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	4e-06	0.00326	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	3.98e-06	0.00324	CbGpPWpGaD
Triamcinolone—PTGS2—Selenium Micronutrient Network—CCL2—multiple sclerosis	3.92e-06	0.00319	CbGpPWpGaD
Triamcinolone—Nausea—Methotrexate—multiple sclerosis	3.91e-06	8.82e-05	CcSEcCtD
Triamcinolone—PTGS2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	3.89e-06	0.00317	CbGpPWpGaD
Triamcinolone—PTGS2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	3.81e-06	0.0031	CbGpPWpGaD
Triamcinolone—NR3C1—Endoderm Differentiation—TGFB1—multiple sclerosis	3.75e-06	0.00305	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—SRM—multiple sclerosis	3.67e-06	0.00299	CbGpPWpGaD
Triamcinolone—NR3C1—AP-1 transcription factor network—MYC—multiple sclerosis	3.67e-06	0.00299	CbGpPWpGaD
Triamcinolone—NR3C1—AP-1 transcription factor network—TGFB1—multiple sclerosis	3.66e-06	0.00298	CbGpPWpGaD
Triamcinolone—PTGS2—Selenium Micronutrient Network—ALB—multiple sclerosis	3.65e-06	0.00297	CbGpPWpGaD
Triamcinolone—PTGS2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	3.62e-06	0.00295	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—TLR4—multiple sclerosis	3.61e-06	0.00294	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—ICAM1—multiple sclerosis	3.46e-06	0.00282	CbGpPWpGaD
Triamcinolone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—multiple sclerosis	3.39e-06	0.00276	CbGpPWpGaD
Triamcinolone—PTGS2—C-MYB transcription factor network—CD4—multiple sclerosis	3.34e-06	0.00272	CbGpPWpGaD
Triamcinolone—PTGS2—Selenium Micronutrient Network—IFNG—multiple sclerosis	3.33e-06	0.00271	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—PABPC1—multiple sclerosis	3.31e-06	0.0027	CbGpPWpGaD
Triamcinolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—multiple sclerosis	3.26e-06	0.00266	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—U2AF2—multiple sclerosis	3.25e-06	0.00265	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—HNRNPA1—multiple sclerosis	3.25e-06	0.00265	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	3.19e-06	0.0026	CbGpPWpGaD
Triamcinolone—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—multiple sclerosis	3.16e-06	0.00258	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—CCL2—multiple sclerosis	3.1e-06	0.00252	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—RPL5—multiple sclerosis	2.99e-06	0.00243	CbGpPWpGaD
Triamcinolone—PTGS2—Selenium Micronutrient Network—IL1B—multiple sclerosis	2.97e-06	0.00242	CbGpPWpGaD
Triamcinolone—NR3C1—Generic Transcription Pathway—PGR—multiple sclerosis	2.94e-06	0.00239	CbGpPWpGaD
Triamcinolone—NR3C1—AP-1 transcription factor network—IL6—multiple sclerosis	2.76e-06	0.00225	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	2.73e-06	0.00223	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—IFNG—multiple sclerosis	2.64e-06	0.00215	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CYP27B1—multiple sclerosis	2.59e-06	0.00211	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CYP24A1—multiple sclerosis	2.59e-06	0.00211	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—ZFP36L1—multiple sclerosis	2.57e-06	0.00209	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—SRM—multiple sclerosis	2.53e-06	0.00206	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	2.48e-06	0.00202	CbGpPWpGaD
Triamcinolone—NR3C1—Glucocorticoid receptor regulatory network—IL6—multiple sclerosis	2.43e-06	0.00198	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—STAT3—multiple sclerosis	2.41e-06	0.00196	CbGpPWpGaD
Triamcinolone—PTGS2—C-MYB transcription factor network—MYC—multiple sclerosis	2.4e-06	0.00196	CbGpPWpGaD
Triamcinolone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	2.38e-06	0.00194	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—GPC5—multiple sclerosis	2.37e-06	0.00193	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—IL1B—multiple sclerosis	2.35e-06	0.00191	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—IL2—multiple sclerosis	2.34e-06	0.00191	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—TGFB1—multiple sclerosis	2.23e-06	0.00182	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—MMP9—multiple sclerosis	2.22e-06	0.0018	CbGpPWpGaD
Triamcinolone—PTGS2—Selenium Micronutrient Network—TNF—multiple sclerosis	2.16e-06	0.00176	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—TNF—multiple sclerosis	2.08e-06	0.0017	CbGpPWpGaD
Triamcinolone—NR3C1—Generic Transcription Pathway—VDR—multiple sclerosis	2.05e-06	0.00167	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—PABPC1—multiple sclerosis	1.99e-06	0.00162	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—RRM1—multiple sclerosis	1.96e-06	0.0016	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—GPC5—multiple sclerosis	1.95e-06	0.00158	CbGpPWpGaD
Triamcinolone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	1.93e-06	0.00157	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—MYC—multiple sclerosis	1.83e-06	0.00149	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—TGFB1—multiple sclerosis	1.83e-06	0.00149	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—TNF—multiple sclerosis	1.8e-06	0.00147	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—RPL5—multiple sclerosis	1.8e-06	0.00146	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—MAPK1—multiple sclerosis	1.79e-06	0.00146	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CYP27B1—multiple sclerosis	1.78e-06	0.00145	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CYP24A1—multiple sclerosis	1.78e-06	0.00145	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.74e-06	0.00142	CbGpPWpGaD
Triamcinolone—PTGS2—Selenium Micronutrient Network—IL6—multiple sclerosis	1.74e-06	0.00142	CbGpPWpGaD
Triamcinolone—BCHE—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	1.71e-06	0.00139	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—TNF—multiple sclerosis	1.71e-06	0.00139	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—IL6—multiple sclerosis	1.68e-06	0.00137	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—GPC5—multiple sclerosis	1.63e-06	0.00133	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.52e-06	0.00124	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—IL6—multiple sclerosis	1.45e-06	0.00118	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—PGR—multiple sclerosis	1.42e-06	0.00115	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—IL6—multiple sclerosis	1.38e-06	0.00112	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—RRM1—multiple sclerosis	1.35e-06	0.0011	CbGpPWpGaD
Triamcinolone—BCHE—Neuronal System—MAPK1—multiple sclerosis	1.31e-06	0.00106	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.31e-06	0.00106	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—RPL5—multiple sclerosis	1.27e-06	0.00103	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.25e-06	0.00101	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.24e-06	0.00101	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.22e-06	0.000992	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—SLC11A1—multiple sclerosis	1.21e-06	0.000987	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.19e-06	0.000971	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.16e-06	0.000945	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—POMC—multiple sclerosis	1.13e-06	0.00092	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—CCL2—multiple sclerosis	1.11e-06	0.0009	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—SRM—multiple sclerosis	1.1e-06	0.000899	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.05e-06	0.000853	CbGpPWpGaD
Triamcinolone—CYP3A4—Biological oxidations—POMC—multiple sclerosis	1.02e-06	0.000833	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—VDR—multiple sclerosis	9.89e-07	0.000805	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CD28—multiple sclerosis	9.68e-07	0.000788	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	9e-07	0.000733	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	8.2e-07	0.000668	CbGpPWpGaD
Triamcinolone—NR3C1—Generic Transcription Pathway—MYC—multiple sclerosis	8.17e-07	0.000665	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	7.78e-07	0.000634	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	7.78e-07	0.000634	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—BCHE—multiple sclerosis	7.75e-07	0.000631	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GPC5—multiple sclerosis	7.12e-07	0.000579	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CD86—multiple sclerosis	6.9e-07	0.000562	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—APOE—multiple sclerosis	6.78e-07	0.000552	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CCR5—multiple sclerosis	6.12e-07	0.000499	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—HLA-A—multiple sclerosis	5.97e-07	0.000486	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—RRM1—multiple sclerosis	5.9e-07	0.00048	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—POMC—multiple sclerosis	5.82e-07	0.000474	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—APOE—multiple sclerosis	5.57e-07	0.000454	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—ALB—multiple sclerosis	5.31e-07	0.000432	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CD80—multiple sclerosis	5.04e-07	0.00041	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—APOE—multiple sclerosis	4.67e-07	0.00038	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—TYK2—multiple sclerosis	4.25e-07	0.000346	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—POMC—multiple sclerosis	4.01e-07	0.000326	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—MYC—multiple sclerosis	3.93e-07	0.00032	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CD4—multiple sclerosis	3.85e-07	0.000313	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ALB—multiple sclerosis	3.65e-07	0.000298	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—BCHE—multiple sclerosis	3.39e-07	0.000276	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—STAT3—multiple sclerosis	2.98e-07	0.000242	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—MYC—multiple sclerosis	2.77e-07	0.000225	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—TGFB1—multiple sclerosis	2.76e-07	0.000225	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—MAPK1—multiple sclerosis	2.71e-07	0.00022	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—IL6—multiple sclerosis	2.08e-07	0.000169	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—APOE—multiple sclerosis	2.04e-07	0.000166	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—POMC—multiple sclerosis	1.75e-07	0.000143	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ALB—multiple sclerosis	1.6e-07	0.00013	CbGpPWpGaD
